Ivabradine Treatment in a Chronic Heart Failure Patient Cohort: Symptom Reduction and Improvement in Quality of Life in Clinical Practice

INTRODUCTION: In the prospective, open-label multicenter INTENSIFY study, the effectiveness and tolerability of ivabradine as well as its impact on quality of life (QOL) in chronic systolic heart failure (CHF) patients were evaluated over a 4-month period. METHODS: In CHF patients with an indication...

Descripción completa

Detalles Bibliográficos
Autores principales: Zugck, Christian, Martinka, Peter, Stöckl, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177104/
https://www.ncbi.nlm.nih.gov/pubmed/25160945
http://dx.doi.org/10.1007/s12325-014-0147-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177104/
https://www.ncbi.nlm.nih.gov/pubmed/25160945
http://dx.doi.org/10.1007/s12325-014-0147-3

Ejemplares similares